Goldman Sachs
-
Pfizer and Greek bailout fund selling as Applied Nutrition launches IPO -
Tech firm to repay part of WMWare financing after biding its time
-
◆ Five year tenor works for investors ◆ Fair value not what it seems ◆ IfDM and Asifnag also price
-
◆ Inflation-linked products ‘more than welcome’ ◆ Record euro linker book ◆ Ten-year plus bid draws demand
-
◆ Issuer scales back size target ◆ Hesse was ‘doing the sensible thing’ ◆ Both short and long-end euros tricky to navigate
-
Favourable conditions could encourage pre-funding for 2025
-
◆ CDC achieves tightening, rare for sterling bonds ◆ ‘A little downside, and a lot of upside’ to two-day execution ◆ Bpifrance prints second sterling deal of 2024
-
◆ AfDB finishes benchmark funding for 2024 ◆ Recent swap moves warrants careful approach ◆ Issuers look for PPs and arb opportunities next
-
A busy pipeline is forming in the SSA market as the EU preps its next scheduled transaction
-
◆ Record size, record book and record investor offers ◆ UK financial year syndication target 80% complete ◆ Demand diversity ‘very notable’
-
VP hired in year of changes for US bank’s SSA desk
-
◆ ’One of the best trades’ from the past two weeks ◆ Dutch agency chooses short maturity ◆ NIPs have ‘crept up’ but deal priced tight
